|
|
Giuseppina Caligiuri, Antonino Nicoletti, Bruno Poirier, Göran K. Hansson
J Clin Invest. 2002;
109(6):745
doi:10.1172/JCI7272
Abstract |
Full text
| PDF

A
therosclerosis is characterized by vascular inflammation and associated with systemic and local immune responses to oxidized LDL (oxLDL) and other antigens. Since immunization with oxLDL reduces atherosclerosis, we hypothesized that the disease might be associated with development of protective immunity. Here we show that spleen-associated immune activity protects against atherosclerosis. Splenectomy dramatically aggravated atherosclerosis in hypercholesterolemic apoE knockout (apoE°) mice. Transfer of spleen cells from atherosclerotic apoE° mice significantly reduced disease development in young apoE° mice. To identify the protective subset, donor spleen cells were divided into B and T cells by immunomagnetic separation before transfer. Protection was conferred by B cells, which reduced disease in splenectomized apoE° mice to one-fourth of that in splenectomized apoE° controls. Protection could also be demonstrated in intact, nonsplenectomized mice and was associated with an increase in antibody titers to oxLDL. Fewer CD4+ T cells were found in lesions of protected mice, suggesting a role for T-B cell cooperation. These results demonstrate that B cell–associated protective immunity develops during atherosclerosis and reduces disease progression.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(37)
| Title and authors |
Publication |
Year |
Accelerated atherosclerosis in patients with SLE—mechanisms and management
Brian J. Skaggs, Bevra H. Hahn, Maureen McMahon
|
Nat Rev Rheumatol
|
2012 |
Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease
Sundararaman Swaminathan, Sudhir V Shah
|
Kidney Int
|
2011 |
The immune system in atherosclerosis
Göran K Hansson, Andreas Hermansson
|
Nat Immunol
|
2011 |
Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention
Maureen McMahon, Bevra H Hahn, Brian J Skaggs
|
Expert Rev Clin Immunol
|
2011 |
Childhood appendectomy, tonsillectomy, and risk for premature acute myocardial infarction--a nationwide population-based cohort study
I. Janszky, K. J. Mukamal, C. Dalman, N. Hammar, S. Ahnve
|
European Heart Journal
|
2011 |
B cell depletion reduces the development of atherosclerosis in mice
H. Ait-Oufella, O. Herbin, J.-D. Bouaziz, C. J. Binder, C. Uyttenhove, L. Laurans, S. Taleb, E. Van Vre, B. Esposito, J. Vilar, J. Sirvent, J. Van Snick, A. Tedgui, T. F. Tedder, Z. Mallat
|
Journal of Experimental Medicine
|
2010 |
The Expression and Functions of Toll-Like Receptors in Atherosclerosis
Jennifer E. Cole, Ektoras Georgiou, Claudia Monaco
|
Mediators of Inflammation
|
2010 |
Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.
Michael Jan, Shu Meng, Natalie C Chen, Jietang Mai, Hong Wang, Xiao-Feng Yang
|
J. Biomed. Biotechnol.
|
2010 |
Understanding immunity requires more than immunology
Kevin J Tracey
|
Nat Immunol
|
2010 |
Depleting B cells in atherosclerosis
Kai-Jye Lou
|
Science-Business eXchange
|
2010 |
|